A centre of vaccine excellence in the UK

We operate from a 74,000 square metre footprint facility and offer a broad spectrum of services, from pre-clinical activity to commercial supply of marketed vaccines, all under one roof. Exclusively focused on vaccines, we have the expertise and technology to identify and eradicate development and manufacturing problems before they arise.

If you are an academic or foundation research team, a small start-up or medium biotech, or a large multinational pharma, VMIC is here to help move your vaccine from discovery towards licensed product and into commercialisation, working with you at any stage in the development process.

 

We are building a UK centre of excellence in vaccine manufacturing, working with partners at every stage of the development process from early analytical work to full commercial scale fill and finish.

Neil Jones, Chief Executive Officer (ad interim), VMIC

During the COVID-19 pandemic we were able to help develop and manufacture the Oxford/ AZ vaccine, and established a rapid national deployment centre for the UK – an incredible effort from all involved.

Rachael Robins, Head of Manufacturing, VMIC

Our Services

Process and analytical development

We have expertise in all stages of process and analytical development.

Drug substance

Our GMP drug substance suites and advanced equipment are available for batches from small scale phase 1 to millions of doses.

Drug product

Wherever your vaccine has been formulated, you can use our GMP fill finish suites to make the final product.

Support and training

We provide support, guidance and knowledge to people working in vaccines, both in the UK and aboard.

Founders and Funders

With our strong roots in academia, industry and government, our purpose is to transform the vaccines sector, ultimately bringing more vaccines to those who need them most.

VMIC has been established as a private company limited by guarantee without share capital.